Cite
HARVARD Citation
Hoeper, M. et al. (2021). Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial. Lancet. 9 (6), pp. 573-584. [Online].